Financials
Financial year 2025
Tewane Pharma from Braine-l'Alleud, company number BE0771699039, closed financial year 2025 with a result of € 41,836 after tax. For that financial year Tewane Pharma recorded a gross margin of € 60,481 and equity of € 101,856. Compared with financial year 2024, the result moved from € 32,764 to € 41,836. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 1, 2026.
€ 101,856
▲ 30% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 41,836
▲ 28% vs 2024
Profit after tax over the fiscal year.
€ 64,575
▲ 20% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 18,118 paid out
43 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
€ 974
▲ € 731 vs 2024
Loans from banks and other lenders, long and short.
€ 612
▼ 93% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 24,558
▼ 7% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 25,721 | € 21,978 | € 51,091 | € 60,481 | ▲ 18% |
| Profit after taxes | € 13,226 | € 11,230 | € 32,764 | € 41,836 | ▲ 28% |
| Equity | € 34,144 | € 45,374 | € 78,138 | € 101,856 | ▲ 30% |
| Total debts | € 31,484 | € 33,779 | € 36,957 | € 47,997 | ▲ 30% |
| Cash | € 12,709 | € 23,336 | € 53,808 | € 64,575 | ▲ 20% |
| Land & buildings | € 12,613 | € 10,476 | € 12,577 | € 9,999 | ▼ 20% |
| Retained profit | € 31,344 | € 42,574 | € 75,338 | € 99,056 | ▲ 31% |
| Dividend | € 0 | € 0 | € 0 | € 18,118 | |
| Bank debt | € 0 | € 0 | € 243 | € 974 | ▲ € 731 |
| Balance sheet total | € 65,628 | € 79,153 | € 115,095 | € 149,853 | ▲ 30% |
Key figures of Tewane Pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Tewane Pharma?
What happened at Tewane Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 41,836 (▲ 28% vs 2024). Source: NBB ↗
- New establishment in Braine-l'Alleud. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 13,226 profit in 2022 to € 41,836 profit in 2025.
Paid € 38,941 in corporate taxes since 2022.
Best year ever: 2025, with € 41,836 profit.
Paid out € 18,118 in dividends to the owners in total.
Establishments
Establishment units
Physical locations of this company
Rue de Lillois 49
1421 Braine-l'Alleud
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- TATIETSE TEWANE Férid(oprichter) 100%
Details
- Company number
- 0771.699.039
- VAT number
- BE 0771.699.039
- Registered office
- Rue de Lillois 49, 1421 Braine-l'Alleud
- Names & denominations
- Tewane Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 July 2021
- Peppol
- Active · Active since 29 May 2026
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op biotechnologisch gebied
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Organisatie van congressen en beurzen
Overige zakelijke dienstverlening, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
+1